PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New innovation could mean eye injections are a thing of the past

2014-03-06
(Press-News.org) Drugs used to treat blindness-causing disorders could be successfully administered by eye drops rather than unpleasant and expensive eye injections, according to new research led by UCL scientists that could be a breakthrough for the millions worldwide suffering from age-related macular degeneration (AMD) and other eye disorders. 1 in 5 people over 75 have AMD with well-known sufferers including actress Dame Judi Dench and author Stephen King. The research findings are significant due to growing patient numbers and an increasing demand for the eye injections that halt the progression of the disease. The research, demonstrated in animal models and published today in nanotechnology journal Small, demonstrates that it is possible to create formulations of tiny nanoparticles loaded with the AMD drug Avastin and deliver significant concentrations to the back of the eye. Lead author Professor Francesca Cordeiro (UCL Institute of Ophthalmology) said: "The development of eye drops that can be safely and effectively used in patients would be a magic bullet – a huge breakthrough in the treatment of AMD and other debilitating eye disorders. "The current treatment of injecting drugs into the eye is uncomfortable, detested by patients and often needs repeated monthly injections in hospital for as long as 24 consecutive months. It's impossible to exaggerate the relief patients would feel at not having to experience injections into their eyes." The NHS is currently overburdened with patients who need repeat eye injections and the numbers are set to rise exponentially over the next ten years. Demand is so high that injections are difficult to administer, time-consuming and very expensive. The treatment also carries a risk of infection and bleeding, increased by the frequency of recurrent injections into the eyes. In the USA, well over one million ocular injections were given in 2010. In the UK, 30,500 injections were estimated to have been given in 2008 – a 150-fold increase in 10 years. Effective delivery of drugs to the retina of the eye is considered one of the most challenging areas in drug development in ophthalmology, due to the presence of anatomical barriers. It was previously thought that drugs used to treat AMD such as Avastin and Lucentis have molecules that are simply too large to be effectively transported in an eye drop. First author Dr Ben Davis (UCL Institute of Ophthalmology) added: "There is significant interest in the development of minimally invasive systems to deliver large drug molecules across biological barriers including the cornea of the eye. "We have shown in experimental models a formulation system to get substances including Avastin across the barriers in the eye and transport them across the cells of the cornea. In theory, you could customise the technology for different drugs such as Lucentis, commonly used for AMD treatment in the UK, as it is a smaller molecule than Avastin so likely to be delivered effectively via this method. "All the components we used are safe and well established in the field, meaning we could potentially move quite quickly to get the technology into trials in patients – but the timescales are dependent on funding." The paper includes functional data showing that the avastin administered stops the blood vessels from leaking and forming new blood vessels, the basis for wet AMD. This technology has been patented by UCL's technology transfer company UCL Business and the researchers are seeking commercial partners to accelerate development. INFORMATION: Notes to Editors: 1. For more information, copies of the paper, or to interview the researchers involved, please contact Ruth Howells in the UCL Media Relations Office on office:+44 (0)20 3108 3845 mobile: +44 (0)7990 675 947, email: ruth.howells@ucl.ac.uk 2. The paper 'Topical Delivery of Avastin to the Posterior Segment of the Eye in vivo using Annexin A5-associated Liposomes' is published online in the journal Small, embargoed until 00.01 UK time on Thursday 6 March 2014. 3. An image of a patient receiving an eye injection (Credit: Saad Younis, Western Eye Hospital) is available on request.


ELSE PRESS RELEASES FROM THIS DATE:

Patients have a right to know -- not a duty to know -- their diagnosis says new research

2014-03-06
The experiences of doctors, patients and carers of initial cancer consultations have informed new guidelines developed at the University of Leicester, in collaboration with University Hospitals of Leicester NHS Trust and Imperial College London, to help patients better understand their cancer consultations. The research, published today (6 March 2014) in the British Journal of Health Psychology, found patients' experiences of being given their diagnosis differed both between participants and within the same participant. This means a doctor's role in communicating information ...

Working pressures increase children attending nursery with respiratory tract infections

2014-03-06
Working parents are often caught between the needs of their sick child and their job, which can lead to continued day care use even when their child is ill. New research has found children going to nursery when they are unwell with respiratory tract infections (RTIs) may be an important factor in the spread of these illnesses in the community. The findings, to be presented today [Thursday 6 March] at the South West Society for Academic Primary Care (SW SPAC) meeting, explored why parents send their children to nursery when they are unwell. The Parents' Choices About ...

How the internet is transforming our experience of being ill

2014-03-06
The last decade has seen a remarkable shift in how people use the internet in relation to their health and it is now talked of as a routine feature of being ill. Professor Sue Ziebland, Director of the Health Experiences Research Group, based in the Nuffield Department of Primary Health Care at the University of Oxford, will share these findings with health practitioners and researchers at the South West Society for Academic Primary Care (SW SAPC) meeting hosted by the Centre for Academic Primary Care at the University of Bristol, today [Thursday 6 March]. This study ...

Low saturated fat diets don't curb heart disease risk or help you live longer

2014-03-06
Diets low in saturated fat don't curb heart disease risk or help you live longer, says a leading US cardiovascular research scientist and doctor of pharmacy in an editorial in the open access journal Open Heart. And current dietary advice to replace saturated fats with carbohydrates or omega 6-rich polyunsaturated fats is based on flawed and incomplete data from the 1950s, argues Dr James DiNicolantonio. Dietary guidelines should be urgently reviewed and the vilification of saturated fats stopped to save lives, he insists. DiNicolantonio points out that the demonisation ...

New 'willful neglect' offense needed for healthcare sector, say lawyers

2014-03-06
A new criminal offence of "wilful neglect" is needed for individuals and organisations in the healthcare sector, to send out a clear message that appalling care warrants public censure and sanction, say leading lawyers in the journal BMJ Quality & Safety. Existing regulation is not up to the job, argue Professors Karen Yeung of The Dickson Poon School of Law, King's College London, and Jeremy Horder of the Department of Law at the London School of Economics. Many patients are just as vulnerable as those who are mentally incapacitated, they point out, yet they do not ...

New terms used for trainee doctors stump nurses and patients

2014-03-06
Nurses and patients are struggling to identify qualified doctors or to grade their seniority from their generic name badges, finds a survey of one hospital in England, published online in BMJ Quality & Safety. The findings prompt the researchers to call for a review of currently used terminology, deployed since the Modernisation of Medical Careers initiative in 2009, which revamped the length of training and introduced a range of new job titles. Staff and patients must be able to correctly identify professional status and communicate effectively, if optimal care is ...

Long-lasting device protects against HIV and pregnancy

2014-03-06
EVANSTON, Ill. --- Women's reproductive health may never be the same, thanks to Northwestern University biomedical engineer Patrick Kiser and his first-of-its-kind intravaginal ring that reliably delivers an antiretroviral drug and a contraceptive for months. Kiser's one ring delivers two drugs that do three important things: the device is designed to protect against HIV and herpes as well as unwanted pregnancy. It will be the first device with the potential to offer this protection to be tested in women. The easy-to-use ring delivers controlled doses of tenofovir (a ...

Gene therapy locks out HIV, paving the way to control virus without antiretroviral drug

2014-03-06
PHILADELPHIA—University of Pennsylvania researchers have successfully genetically engineered the immune cells of 12 HIV positive patients to resist infection, and decreased the viral loads of some patients taken off antiretroviral drug therapy (ADT) entirely—including one patient whose levels became undetectable. The study, appearing today in the New England Journal of Medicine, is the first published report of any gene editing approach in humans. The phase I study was co-authored by researchers at Penn Medicine, the Albert Einstein College of Medicine and scientists ...

Human activity influences beach bacterial diversity

2014-03-06
Human activity influences ocean beach bacterial communities, and bacterial diversity may indicate greater ecological health and resiliency to sewage contamination, according to results published March 5, 2014, in the open access journal PLOS ONE by Elizabeth Halliday from Woods Hole Oceanographic Institution and colleagues. Beaches all contain bacteria, but some bacteria are usually from sewage and may contaminate the water, posing a public health risk. In this study, scientists studied bacterial community composition at two distant beaches (Avalon, California, and Provincetown, ...

New dinosaur found in Portugal, largest terrestrial predator from Europe

New dinosaur found in Portugal, largest terrestrial predator from Europe
2014-03-06
A new dinosaur species found in Portugal may be the largest land predator discovered in Europe, as well as one of the largest carnivorous dinosaurs from the Jurassic, according to a paper published in PLOS ONE on March 5, 2014 by co-authors Christophe Hendrickx and Octavio Mateus from Universidade Nova de Lisboa and Museu da Lourinhã. Scientists discovered bones belonging to this dinosaur north of Lisbon. They were originally believed to be Torvosaurus tanneri, a dinosaur species from North America. Closer comparison of the shin bone, upper jawbone, teeth, and partial ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] New innovation could mean eye injections are a thing of the past